Fecal transplants show promise in reducing autism symptoms as research moves to Phase 3 trials

Summary

This article discusses the emerging scientific connection between gut microbiome health and autism spectrum disorder. It highlights new research showing that fecal microbiota transplants (FMT), which boost microbial diversity in the gut, can dramatically reduce autism symptoms in the long term. The research is moving into Phase 3 human trials, representing a significant step forward in understanding the gut-brain axis and its role in neurodevelopmental conditions. The article was originally published in 2019 and includes an editor's note about reader interest in follow-ups on memorable stories.